Monday, March 9, 2009

Pathology of cardiomyopathy

While I am preparing for my master degree exam - 1st part, I noticed the topic of cardiomyopathy is much frequently encountered in pathology exams. I also noticed that our Egyptian pathology books are very deficient when dealing with this important topic. So, I decided to write it myself collecting data from different Pathology texts. It was "Robin's basic pathology, 8th ed" which I found most informative and well-organized and most of data here are derived from it.


Cardiomyopathy

Definition

Group of diseases that primarily involve the myocardium and produce myocardial dysfunction (or intrinsic disease of the cardiac muscle)

Types of cardiomyopathy

1. Dilated (congestive)

2. Hypertrophic

3. Restrictive

click image to enlarge


Dilated cardiomyopathy

  1. Epidemiology
    1. Incidence: Most common cardiomyopathy (90% of cases)

The incidence of this disorder in Europe and North America is 2-8 cases per 100 000 per year. The median age at presentation is about 50 years but young adults may be affected.

    1. Etiology:
      1. Idiopathic (most common)
      2. Genetic causes (25-35%)
      3. Myocarditis (usually postviral myocarditis with coxsackievirus B)
      4. Toxic: e.g., doxorubicin(adriamycin), cocaine and cobalt.
      5. Postpartum state
      6. Alcoholism:can cause thiamine deficiency in addition to the acetaldehyde (alcohol metabolite) which is toxic to the myocardium.
  1. Pathophysiology
    1. Decreased contractility with a decreased EF (<40%)>
    2. Systolic dysfunction type of left ventricular failure
  2. Gross picture:
    1. Global enlargement of the heart (the heart is 2-3 times the normal size and flobby)
      1. All chambers are dilated.
      2. Echocardiography shows poor contractility and mural thrombi may be present.
      3. No significant 1ry valvular disease (except for functional regurgitation 2ry to ventricular chamber enlargement)
      4. No significant affection of the coronary arteries.
  3. Microscopic picture:

The histologic abnormalities in DCM are nonspecific. Microscopically most myocytes are hypertrophied with enlarged nuclei, but many are attenuated, stretched, and irregular. There is variable interstitial and endocardial fibrosis; scattered scars are also often present, probably marking previous myocyte ischemic necrosis caused by reduced perfusion (due to poor contractile function) and increased demand (due to myocyte hypertrophy). The extent of the changes frequently does not reflect the degree of dysfunction or the patient's prognosis.

  1. Complications:
    1. Biventricular CHF
    2. Bundle branch blocks
    3. Atrial and ventricular arrhythmias
    4. Mural thrombi and systemic embolisation
  2. Prognosis: poor and only 50-60% of patients survive 2 years after presentation.


click image to enlarge


Hypertrophic cardiomyopathy

  1. Epidemiology
    1. Most common cause of sudden death in young individuals
    2. Familial form (autosomal dominant) in young individuals (majority of cases)
      • Due to mutations in heavy chain of β-myosin and in the troponins
    3. Sporadic form in elderly people
  2. Pathophysiology
    1. Hypertrophy of the myocardium
      • Disproportionately greater thickening of the interventricular septum than of the free left ventricular wall
    2. Obstruction of blood flow is below the aortic valve
      • Anterior leaflet of the mitral valve is drawn against the asymmetrically hypertrophied septum as blood exits the left ventricle.
    3. Aberrant myofibers and conduction system in the interventricular septum
      • Conduction disturbances are responsible for sudden death.
    4. Decreased diastolic filling: Muscle thickening restricts filling.
  3. Gross picture:

- massive myocardial hypertrophy without ventricular dilation

- disproportionate thickening of the ventricular septum relative to the left ventricle free wall

- On longitudinal sectioning, the ventricular cavity loses its usual round-to-ovoid shape and is compressed into a "banana-like" configuration

- an endocardial plaque in the left ventricular outflow tract is often present with thickening of the anterior mitral leaflet. This is correlated to contact between the anterior mitral valve leaflet and the septum during late systole (dynamic obstruction)

  1. Microscopic picture:

- severe myocyte hypertrophy

- myocyte (and myofiber) disarray

- interstitial and replacement fibrosis

  1. Complications and Prognosis:
    1. Heart failure: due to impaired diastolic filling and dynamic outflow tract obstruction (in 25% of cases).
    2. Arrythmias: atrial and ventricular arrhythmias and heart block.
    3. Infective endocarditis of the mitral valve.
    4. Sudden cardiac death: the most common cause of SCD in young adults.


click image to enlarge


Restrictive cardiomyopathy

  1. Etiology
    1. Tropical endomyocardial fibrosis: the most common cause worldwide
    2. Infiltrative diseases
      • Examples-Pompe's glycogenosis, amyloidosis, hemochromatosis
    3. Endocardial fibroelastosis in a child (thick fibroelastic tissue in the endocardium), sarcoidosis
  2. Pathophysiology

a. Decreased ventricular compliance

b. Usually secondary to infiltrative disease of the myocardium

c. Diastolic dysfunction type of LHF

  1. Gross picture:

- The ventricles are of approximately normal size or slightly enlarged, the cavities are not dilated, and the myocardium is firm.

- Biatrial dilation is commonly observed.

  1. Microscopic picture:

- interstitial fibrosis, varying from minimal and patchy to extensive and diffuse

- disease-specific features can be seen on endomyocardial biopsy (e.g., amyloid, iron overload, sarcoid granulomas).

  1. Prognosis and complications: CHF and Arrhythmias (conduction defects)

Saturday, February 14, 2009

Swanton's Cardiology

This is a really good book for cardiology. I recommend it to all fellows.


Swanton's Cardiology
By R. Howard Swanton, Shrilla Banerjee
  • Publisher: Wiley-Blackwell
  • Number Of Pages: 696
  • Publication Date: 2008-04-11
  • ISBN-10 / ASIN: 1405178191
  • ISBN-13 / EAN: 9781405178198
You can download it from here:

Download link

Wednesday, January 14, 2009

Back to basics: ECG criteria of atrial enlargement

Righ Atrial Enlargement (RAE):
  • In lead II: Peaked P wave (A-like appearance)
  • Normal P-wave duration
  • Increase in the maximal amplitude of the P wave to >0.20 mV in leads II and aVF, and to >0.10 mV in leads V1 and V2

Left Atrial Enlargement (LAE):
  • In lead II: gives a notch in the P-wave followed by a second hump (M-like appearance)
  • Prolonged P-wave duration(>0.12s) and prollongation of the negative terminal portion of P-wave in lead V1
  • Increase only in the amplitude of the terminal negatively directed portion of the P-wave in lead V1 to >0.10 mV






ECGs of patients with atrial enlargement. Arrows, P-wave changes in atrial enlargement; asterisks, left-atrial enlargement.(click image to enlarge)

Good book: ACLS Review: Pearls of Wisdom

ACLS Review: Pearls of Wisdom



A very nice book that will help you to master all knowledge needed for ACLS in almost every possible situation. It is in the form of Q&A which makes it more interesting. You can download the 6mb pdf document from either links below.



link 1



link2

New guidelines for appropriateness for coronary revascularization

These are the recently released guidelines to help in decision making regarding coronary revascularization. They ilustrate 180 possible scenarios and help with appropriate decision in each. you can download the pdf file from here:

http://content.onlinejacc.org/cgi/reprint/j.jacc.2008.10.005v1.pdf.

And do not forget to get your CME credit from medscape here:

http://www.medscape.com/viewarticle/586383

Thursday, January 8, 2009

Echocardiography Basics explained by video

Here is a basic echocardiography course presented by some Indian university as a part of postgraduate diploma on cardiology. The resolution is not so good but acceptable. The videos is a very good start as I think.
part 1

part 2

part 3

part4

The way you think about COPD may change after you read this

Here is an interesting article about the relation between COPD and cardiovascular risks. I think it may change your way of thinking when you dealing with COPD patients either with associated cardiovascular disease or not.